SCHEMBL26324873

SCHEMBL26324873

CC(C)OC(=O)C(C(C)C)N(C)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.41
PDCD1 Q15116 1/20 0.40
CD274 Q9NZQ7 1/20 0.40
CHRNB2 P17787 1/20 0.40
CHRNB4 P30926 1/20 0.40
CHRNA3 P32297 1/20 0.40
CHRNA4 P43681 1/20 0.40
MMP2 P08253 2/20 0.37
MMP9 P14780 2/20 0.37
MMP8 P22894 2/20 0.37
MMP13 P45452 2/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
SLC6A2 P23975 2/20 0.37
SLC6A4 P31645 2/20 0.37
GAA P10253 1/20 0.37
KDM4E B2RXH2 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
ADAMTS4 O75173 1/20 0.37
MMP3 P08254 1/20 0.37
MMP12 P39900 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26324800 0.85 TSHR (0.42) TSHRPDCD1CD274CHRNB2CHRNB4
SCHEMBL25439821 0.83 TSHR (0.43) TSHRPDCD1CD274CHRNB2CHRNB4
SCHEMBL3340749 0.80 ADAMTS4 (0.49) TSHRCHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL3340746 0.80 ADAMTS4 (0.49) TSHRCHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL26324955 0.78 PDCD1 (0.50) TSHRPDCD1CD274MMP2MMP9
SCHEMBL26324940 0.78 TRPM8 (0.39) TSHRPDCD1CD274MMP2MMP9
SCHEMBL31467993 0.77 SLC6A2 (0.44) TSHRCHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL26324941 0.77 TSHR (0.46) TSHRCHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL26324875 0.77 TRPM8 (0.36) TSHRPDCD1CD274CHRNB2CHRNB4
SCHEMBL26325014 0.76 PDCD1 (0.51) TSHRPDCD1CD274MMP2MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11767291-B2 Preparation of secondary amines with electrophilic N-linchpin reagents WILLIAM MARSH RICE UNIVERSITY (US) 2023-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11767291-B2 Preparation of secondary amines with electrophilic N-linchpin reagents PNMT, NCL, NPM1 TSHR 2716/4885PDCD1 3686/4885CD274 4128/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.